Etomidate
Overview
Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation for short procedures. It is known for its stable hemodynamic profile and minimal effect on cardiovascular function.
API suppliers (7)
Suppliers of Etomidate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
4 of 7 hold a GMP certificate on record in the EU or UK registers
- BACHEM INCSwitzerland1 active DMF GMP on record
- GLAND PHARMA LTDIndia1 active DMF GMP on record
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
- PISGAH LABS INCUnited States1 active DMF
- CHEMWERTH INCFrance1 active DMF
- RELIABLE BIOPHARMACEUTICAL CORPUnited States
- Janssen Pharmaceutica NVBelgium GMP on record
EU CEP holders (4)
Companies holding a valid EU Certificate of Suitability (CEP) for Etomidate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Etomidate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.